Wordt geladen...
Analysis of different HER‐2 mutations in breast cancer progression and drug resistance
Studies over the last two decades have identified that amplified human epidermal growth factor receptor (HER‐2; c‐erbB‐2, neu) and its overexpression have been frequently implicated in the carcinogenesis and prognosis in a variety of solid tumours, especially breast cancer. Lots of painstaking effor...
Bewaard in:
| Gepubliceerd in: | J Cell Mol Med |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4687700/ https://ncbi.nlm.nih.gov/pubmed/26305917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12662 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|